China’s pharmaceutical export markets span North America, Europe, Asia, Latin America, Africa, and Oceania. Pharmaceutical exports from China are expanding from traditional APIs and generic medicines to finished formulations, biological products, and innovative medicines. Based…
In the first half of 2026, the field of rare disease drugs in China continued to see new regulatory approvals, including six innovative medicines. DengYueMed reviews these medicines based on their approval dates, primary indications,…
Key Takeaways As international interest in Chinese medicines and pharmaceutical resources continues to grow, finding convenient ways to understand medicines and related pharmacy services in China has become an important part of cross-border healthcare. Against…
With its pharmaceutical innovation engine roaring, China has become a premier destination to buy medicine in China‘s rapidly expanding market. The opportunity to buy medicine in China has never been more compelling. In just two days, domestic innovative…
Gone are the days of waiting in long queues at hospitals or visiting local drugstores for minor health needs. Today, Chinese drugstore online services have made everything simple—with just a few taps on your smartphone, medications can…
A Chinese pharmacy is an important channel for learning about and accessing medicines available in China. With the development of online pharmacy services, overseas users can now search for Chinese medicines online, learn about product…
Liver cancer, especially advanced hepatocellular carcinoma (HCC), is increasingly treated with targeted therapy and immunotherapy as important systemic treatment approaches. So, what are the targeted and immunotherapy drugs for liver cancer? What are the differences…
According to publicly available information, 38 innovative drugs were approved for marketing in China in the first half of 2026, including 31 domestically developed innovative drugs. Among them, 15 innovative drugs were approved in the…
The breast cancer drug list in China mainly includes endocrine therapy drugs, HER2-targeted drugs, CDK4/6 inhibitors, mTOR inhibitors, PARP inhibitors, antibody-drug conjugates (ADCs), chemotherapy drugs, and immunotherapy drugs. Breast cancer is one of the most…
Common drugs for prostate cancer include androgen deprivation therapy (ADT), androgen receptor pathway inhibitors (ARPIs), PARP inhibitors, chemotherapy, PSMA-targeted radioligand therapy, immunotherapy, and bone-targeted therapies. Prostate cancer is one of the most common cancers affecting…
For patients living with transfusion-dependent beta thalassemia (TDT), lifelong blood transfusions have long been the standard of care. While effective in maintaining hemoglobin levels, this approach brings a significant burden—requiring frequent transfusions and continuous iron…
Lung cancer remains the leading cause of cancer death worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of cases. Thanks to advances in molecular pathology, its treatment has shifted from traditional chemotherapy…
